KR0148546B1 - Process for preparing interpenetrating polymer network film of chitin for an artificial skin - Google Patents
Process for preparing interpenetrating polymer network film of chitin for an artificial skin Download PDFInfo
- Publication number
- KR0148546B1 KR0148546B1 KR1019950019960A KR19950019960A KR0148546B1 KR 0148546 B1 KR0148546 B1 KR 0148546B1 KR 1019950019960 A KR1019950019960 A KR 1019950019960A KR 19950019960 A KR19950019960 A KR 19950019960A KR 0148546 B1 KR0148546 B1 KR 0148546B1
- Authority
- KR
- South Korea
- Prior art keywords
- chitin
- artificial skin
- weight
- film
- organic solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
- A61F2/105—Skin implants, e.g. artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/915—Method or apparatus for preparing biological material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
Abstract
본 발명은 인공피부용 키틴계 상호침투구조 필름의 제조방법에 관한 것으로, 좀 더 상세하게는 키틴 10~90중량%와 분자량이 100~20,000인 폴리에틸렌글리콜 마크로머 10~90중량%를 유기용매 존재하에서 반응시킨 다음, 상기 반응물에 자외선 경화촉진제를 첨가시켜 10~120분간 자외선 경화시키는 인공피부용 키틴계 상호침투구조 필름의 제조방법에 관한 것이다. 상기 필름은 키틴에 습윤시 강도를 보강하여 분해흡수성 인공피부 또는 수술용 봉합사로 사용가능하다.The present invention relates to a method for producing a chitin-based interpenetrating structure film for artificial skin, and more specifically, 10 to 90% by weight of chitin and 10 to 90% by weight of polyethylene glycol macromer having a molecular weight of 100 to 20,000 in the presence of an organic solvent. After the reaction, the method relates to a method for producing a chitin-based interpenetrating structure film for artificial skin which is cured by adding an ultraviolet curing accelerator to the reactant for 10 to 120 minutes. The film can be used as decomposed absorbent artificial skin or surgical sutures by reinforcing strength when wet with chitin.
Description
본 발명은 인공피부용 키틴계 상호침투구조(Interpenetrating Polymer Networks, IPN) 필름의 제조방법에 관한 것으로, 좀 더 상세하게는 키틴의 습윤시 강도를 보강하여 분해흡수성 인공피부로 사용가능한 키틴계 상호침투구조 필름의 제조방법에 관한 것이다.The present invention relates to a method for manufacturing an interpenetrating polymer network (IPN) film for artificial skin, and more particularly, to a chitin-based interpenetrating structure that can be used as a decomposed absorbent artificial skin by reinforcing strength when the chitin is wet. It relates to a method for producing a film.
키틴은 결정구조상 추출되는 원료에 따라 α, β 및 γ 등의 키틴으로 분리할 수 있다. α-키틴은 새우, 게 등의 갑각류에서 얻을 수 있으며, 결정구조는 사방정계를 이루며 분자사슬이 서로 교대로 배열된 구조로 되어있고, β-키틴은 단사정계를 이루고 분자사슬이 평행배열된 구조를 이루며 꼴뚜기 뼈에서 추출될 수 있다. 그리고 γ-키틴은 α와 β구조의 키틴혼합물로 이루어져 있다.Chitin can be separated into chitin, such as α, β, and γ, depending on the raw material extracted from the crystal structure. α-chitin can be obtained from crustaceans such as shrimp and crab, and the crystal structure is tetragonal and molecular chains are alternately arranged. β-chitin is monoclinic and molecular chains are arranged in parallel. It can be extracted from the pod bones. And γ-chitin is composed of chitin mixture of α and β structure.
α-키틴은 분자내·분자간의 수소결합에 의한 강한 미셀구조의 형성으로 용매에 대한 저항성이 커서 일반적 유기용매에 팽윤되기가 어렵다. 또한, 화학반응성이 낮아 키틴 유도체의 제조에도 많은 난점이 따르고 있다. 더군다나, 키틴은 석회질이 많은 갑각류에서 추출하기 떼문에 갑각류로 분리 분리한 후에도 칼슘성분이 일부 존재하고 있다.α-chitin is resistant to solvents due to the formation of strong micelle structures by intramolecular and molecular hydrogen bonding, which makes it difficult to swell in general organic solvents. In addition, there is a lot of difficulties in the production of chitin derivatives due to low chemical reactivity. Moreover, because chitin is extracted from calcareous crustaceans, some of the calcium is still present after separation into crustaceans.
반면에 꼴뚜기 뼈에서 추출한 β-키틴은 결합구조상의 차이로 강산 또는 일부 약산에서도 용해가 가능하며 쉽게 유기용매의 팽윤이 일어나 α-키틴에 비하여 화학반응성이 우수하고, 금속성분의 비교에서 칼슘성분이 낮을 수 있어 더 순수한 키틴을 얻을 수 있다. 키틴을 산과 알칼리로 처리하면 키토산이 되는데 이것은 물에 팽윤될 수 있고, 키틴의 결정성이 파괴될 수 있으나, 훨씬 큰 수용성 물질이 될 수 있다.On the other hand, β-chitin extracted from podaceous bone can be dissolved in strong acid or some weak acid due to the difference in binding structure, and swelling of organic solvent is easy, resulting in better chemical reactivity compared to α-chitin. It can be low, resulting in a purer chitin. Treatment of chitin with acids and alkalis results in chitosan, which can swell in water and destroy the crystallinity of chitin, but it can be a much larger water-soluble substance.
키틴과 키틴을 탈아세틸화시킨 키토산, 그리고 각각의 유도체들을 제조하여 강산이나 약산 또는 DMAc-LiCl 등을 이용한 유기용매 또는 혼합용매에 용해시키고, 관능기를 결합시켜 섬유와 종이, 의약, 식품, 화장품, 폐수처리 등 다양한 방면에 응용이 가능하다.Chitin and chitosan deacetylated chitin and its derivatives are prepared and dissolved in an organic solvent or mixed solvent using strong acid, weak acid, or DMAc-LiCl, and combined with functional groups to form fibers, paper, medicine, food, cosmetics, It can be applied to various fields such as wastewater treatment.
종래에 키틴을 이용한 IPN의 제조에 관하여는 보고되어 있지 않다. 키토산을 이용해 IPN을 제조하고 팽윤거동과 약물 방출을 살펴본 논문은 Yao 등에 의해 발표된 바 있다(Journal of Polymer Science: Part A. Polymer Chemistry, Vol. 32, p.1213-1223(1994)). 일반적으로 키토산보다는 키틴이 강한 미셀구조를 가지고 있어 가교구조가 되어서도 습윤시 강한 기계적 강도를 가질 것으로 판단된다. IPN의 형성에 관하여는 수많은 보고가 있다. 그러나 의료용 고분자에의 응용에 대하여는 보고되어 있지 않다.There is no conventional report on the preparation of IPN using chitin. A paper on the preparation of IPN using chitosan and the swelling behavior and drug release has been published by Yao et al. (Journal of Polymer Science: Part A. Polymer Chemistry, Vol. 32, p. 1213-1223 (1994)). In general, chitin has a stronger micelle structure than chitosan, and thus, even when crosslinked, the chitin has a strong mechanical strength when wet. There are numerous reports about the formation of IPNs. However, there are no reports on their application to medical polymers.
피부는 외부로부터 생체를 보호하는 최전선에 위치한 기관으로서 피부가 손상을 입게되면 위험한 상황에 노출되기 쉽다. 피부의 기능은 복잡하여 인공적으로 제조된 피부 대체물은 피부가 가지는 기능을 모두 수행할 수 없지만, 상처를 보호할 수 있다. 인공피부는 임상적인 관점에서 일시적으로 발생된 피부의 상처를 보호할 목적으로 사용하는 것과 영구부착을 목적으로 하는 것으로 분류할 수 있다. 전자는 상처피부제, 동종피부, 타가배양피부 등으로 실제로 피부를 대행할 수 있는 기능을 가지고 있다. 이에 반해 후자는 자신의 건강한 피부로 부터 채취한 선유아세포 또는 각질세포를 시험관내(in vitro)에서 배양하여 피부구조의 일부를 구축하는 것으로서 자가배양피부라고도 한다.The skin is at the forefront of protecting the body from the outside, and if the skin is damaged, it is likely to be exposed to dangerous situations. The function of the skin is complex and artificially manufactured skin substitutes cannot perform all the functions of the skin, but can protect the wound. Artificial skin can be categorized as used for the purpose of protecting the temporary wound from the clinical point of view and for permanent attachment. The former has the function of actually acting on the skin as wound skin, allogeneic skin, and other cultured skin. On the other hand, the latter is also known as self-cultivated skin by culturing fibroblasts or keratinocytes from their healthy skin in vitro and constructing a part of the skin structure.
인공피부가 필요한 경우는 화상을 치료하는 경우이다. 광범위한 중상의 열상을 받은 환자의 경우, 수술로 피부결손부를 자가 피부이식할 수 있다. 따라서, 자가피부이식이 가능할 때까지 일시적인 피부의 보호를 목적으로 인공피부가 필요하다. 이러한 상처피복제 또는 인공피부로는 콜라겐, 알긴산칼슘염, 키토산 부직포, 하이아론산 부직포, 폴리우레탄막, 실리콘막 등이 사용되고 있다. 그러나, 상기 상퍼 피복제가 피부로 부터 나오는 진물을 흡수하면 강도가 현저히 떨어지는 단점을 가지고 있어 이를 개선하고저 노력이 진행중이다.The need for artificial skin is the treatment of burns. In patients with extensive severe lacerations, the skin defect can be autografted by surgery. Therefore, artificial skin is required for the purpose of temporary skin protection until autologous skin transplantation is possible. As such wound coating or artificial skin, collagen, calcium alginate salt, chitosan nonwoven fabric, hyaluronic acid nonwoven fabric, polyurethane film, silicone film and the like are used. However, the absorber has a disadvantage in that the strength is significantly reduced when absorbing the ooze coming from the skin has been improved and low effort is in progress.
본 발명자들은 이러한 재래식 인공피부의 단점을 개선하고자 예의 연구하던바 키틴을 망상가교구조로 형성시키면 습윤시에도 기계적 강도가 높다는데 착안하여 본 발명에 이르렀다.The present inventors earnestly studied to improve the shortcomings of the conventional artificial skin, and when the chitin is formed into a crosslinked structure, the present inventors have realized that the mechanical strength is high even when wet.
따라서, 본 발명의 목적은 분해흡수성 인공피부, 수술용 봉합사 등에 사용가능한 키틴계 상호침투구조 필름의 제조방법을 제공하는데 있다.Accordingly, it is an object of the present invention to provide a method for producing a chitin-based interpenetrating structure film which can be used for disintegrating absorbent artificial skin, surgical suture, and the like.
상기 목적을 달성하기 위한 본 발명의 방법은 키틴 10~90중량%와 분자량이 100~20,000인 폴리에틸렌글리콜 마크로머(PEG macromer) 10~90중량%를 유기용매 존재하에서 혼합한 다음, 상기 혼합물에 자외선 경화촉진제를 첨가시켜 10~120분간 자외선 경화시키는 것으로 이루어진다.The method of the present invention for achieving the above object is a mixture of 10 to 90% by weight of chitin and 10 to 90% by weight of polyethylene glycol macromer (PEG macromer) having a molecular weight of 100 to 20,000 in the presence of an organic solvent, and then ultraviolet light to the mixture A curing accelerator is added to cure ultraviolet light for 10 to 120 minutes.
이하 본 발명의 제조방법을 좀 더 구체적으로 설명하면 다음과 같다.Hereinafter, the manufacturing method of the present invention will be described in more detail.
본 발명에 따르면, 상기 키틴계 상호침투구조 필름은 키틴 10~90중량%와 분자량이 100~20,000인 폴리에틸렌글리콜 마크로머 10~90중량%를 유기용매 존재하에서 블렌딩하여 잘 혼화시킨다. 이때, 키틴과 폴리에틸렌글리콜 마크로머의 혼합물의 양은 유기용매에 대하여 2~10중량%의 범위로 용해시키는 것이 효율면에서 바람직하다. 그 다음, 상기 혼합물에 자외선 경화촉진제를 상기 혼합물의 고형분 100중량부에 대해 10~35중량부의 양으로 첨가시키고 유리판에 유연(casting)한다. 이때 적절한 용매에 용해시켜 첨가시킨다. 그후, 상기 혼합물을 상호침투 가교구조로 형성시키기 위해 자외선 램프로 10~120분간 자외선으로 경화시킴으로써 용액상으로부터 상호침투구조를 갖는 반고체상의 겔 형태로 전이가 일어나고, 이어서 기재에 남아 있는 여분의 용매를 감압오븐에서 건조하여 표면이 치밀한 형상을 갖는 인공피부용 키틴계 상호침투구조 필름을 제조한다. 이렇게 제조돈 본원발명의 인공피부용 키틴계 상호침투구조 필름은 폴리에틸렌글리콜 마크로머가 가교되고, 키틴은 가교된 폴리에틸렌글리콜 마크로머 사슬위에 선형으로 결합되어 있는 화학구조를 경유하여 달성된다.According to the present invention, the chitin-based interpenetrating film blends 10 to 90% by weight of chitin and 10 to 90% by weight of polyethylene glycol macromer having a molecular weight of 100 to 20,000 in the presence of an organic solvent to mix well. At this time, the amount of the mixture of chitin and polyethylene glycol macromer is preferably dissolved in the range of 2 to 10% by weight with respect to the organic solvent in terms of efficiency. The UV curing accelerator is then added to the mixture in an amount of 10 to 35 parts by weight based on 100 parts by weight of the solids of the mixture and cast on a glass plate. At this time, it is dissolved in an appropriate solvent and added. Thereafter, the mixture is cured with ultraviolet lamps for 10 to 120 minutes with an ultraviolet lamp to form an interpenetrating crosslinked structure, whereby a transition occurs from a solution phase into a semisolid gel form having an interpenetrating structure, and then the excess solvent remaining in the substrate is removed. Drying in a reduced pressure oven to prepare a chitin-based interpenetrating structure film for artificial skin having a dense surface. Thus prepared chitin interpenetrating structure film for artificial skin of the present invention is crosslinked by polyethylene glycol macromers, chitin is achieved through a chemical structure that is linearly bonded on the crosslinked polyethylene glycol macromer chain.
한편, 본 발명에 사용가능한 키틴은 α-키틴, β-키틴 또는 γ-키틴을 포함하지만, 오징어, 갑오징어, 꼴뚜기 또는 한치 등을 포함하는 꼴뚜기류의 뼈를 추출하여 산과 알칼리로 처리하여 칼슘과 단백질을 제거한 β-키틴이 바람직하다.On the other hand, chitin usable in the present invention includes α-chitin, β-chitin or γ-chitin, but extracts bones of squids, including squid, cuttlefish, squid, or cuttlefish, and treated with acid and alkali to treat calcium and Β-chitin without protein is preferred.
상기 폴리에틸렌글리콜 마크로머는 폴리에틸렌글리콜디메타크릴레이트, 폴리에테르디메타크릴레이트, 폴리프로필렌글리콜디메타크릴레이트 또는 폴리에스테르디메타크릴레이트 등이 본 발명에 바람직하지만, 이에 한정되는 것은 아니다.The polyethylene glycol macromer is preferably polyethylene glycol dimethacrylate, polyether dimethacrylate, polypropylene glycol dimethacrylate or polyester dimethacrylate, but is not limited thereto.
본 발명에 사용될 수 있는 유기용매로는 포름산, 아세트산 또는 삼불화아세트산이 바람직하며, 상기 자외선 경화촉진제로는 벤조페논, 아세토페논, 안트라퀴논, 잔톤, 캄포퀴논, 플르오레논 또는 이들의 유도체 등을 사용할 수 있지만, 이에 한정되는 것은 아니다.The organic solvent that can be used in the present invention is formic acid, acetic acid or trifluoroacetic acid is preferred, the UV curing accelerator is benzophenone, acetophenone, anthraquinone, xanthone, campoquinone, fluorenone or derivatives thereof Although it can use it, it is not limited to this.
상기 자외선 경화촉진제의 첨가시 사용되는 용매로는 N-비닐피롤리돈, N-메틸피롤리돈, 디메틸포름아미드, 디메틸아세트아미드 또는 디메틸술폭사이드 등이 있다.Solvents used in the addition of the UV curing accelerator include N-vinylpyrrolidone, N-methylpyrrolidone, dimethylformamide, dimethylacetamide or dimethyl sulfoxide.
한편, 상기 방법으로 제조된 필름은 수술용 봉합사, 인공피부등으로 사용이 가능하나 이에 제한받지는 않는다. 어떤 재료가 인공피부로 사용 가능하려면, 창상부위로부터 삼출액이 인공피부재료에 흡수되어도 기계적 강도가 저하되지 않은 상태로 유지되야 하므로 사용 습윤지 팽윤 기계적 강도가 1MPa 이상 바람직하게는 2MPa 이상이 되어야 하고, 건조상태의 강도가 20MPa 이상이 되어야 하는데 본 발명의 키틴계 IPN은 상기 조건을 만족시킨다.On the other hand, the film produced by the above method can be used as a surgical suture, artificial skin, but is not limited thereto. In order for a material to be used as an artificial skin, the wetted swelling mechanical strength should be 1 MPa or more, preferably 2 MPa or more, since the mechanical strength should not be lowered even if the exudates from the wound are absorbed by the artificial skin material. The dry strength should be 20 MPa or more, but the chitin-based IPN of the present invention satisfies the above conditions.
이하 실시예 및 비교예를 통하여 본 발명의 방법 및 효과를 좀더 구체적으로 살펴보지만, 하기예에 본 발명의 범주가 한정되는 것은 아니다.Hereinafter, the method and effect of the present invention will be described in more detail with reference to Examples and Comparative Examples, but the scope of the present invention is not limited to the following Examples.
제조예(PEG 마크로머의 제조)Production example (production of PEG macromer)
PEG 분자량 4000, 6000, 10,000, 20,000의 시약 2×10-3몰을 150㎖의 벤젠에 녹이고 0℃까지 온도를 낮춘 유리용기에 저장한다. 0.7㎖의 트리에틸아민과 0.7㎖의 아크릴로일 클로리드를 상기 유리용기에 첨가시켜 3시간동안 교반하면서 약 80℃에서 반응시킨다. 유리용기내의 반응물을 지방족 탄화수소인 n-헥산에 부어 폴리에틸렌글리콜리메타크릴레이트를 제조하고 40℃에서 1일간 10mmHg 이하의 오븐에서 감압, 건조한다.2 x 10 -3 mol of reagents of PEG molecular weight 4000, 6000, 10,000, and 20,000 are dissolved in 150 ml of benzene and stored in a glass vessel cooled to 0 ° C. 0.7 ml of triethylamine and 0.7 ml of acryloyl chloride are added to the glass vessel and reacted at about 80 ° C. with stirring for 3 hours. The reactant in the glass vessel is poured into n-hexane, an aliphatic hydrocarbon, to prepare polyethylene glycol methacrylate, and dried under reduced pressure in an oven of 10 mmHg or less at 40 ° C. for 1 day.
[실시예 1 내지 12][Examples 1 to 12]
상기 제조예에서 제조된 각 분자량의 폴리에틸렌글리콜디메타크릴레이트와 β-키틴을 하기 표 1에 기재된 조성비로 혼합한후, 상기 혼합물 2.4중량%를 포름산 용액에 녹이고 질소 분위기 하에서 30분간 방치한후 0.3g의 2,2-디메톡시-2-페닐아세트페놀을 1㎖의 N-비닐피롤리돈에 녹인 용액을 유리판에 유연하여 450W 자외선 램프에서 약 60분간 경화시키고 나서 기재에 남아있는 여분의 용매를 감압오븐에서 건조하여 표면이 치밀한 형상을 갖는 본 발명에 따른 키틴계 상호침투구조 필름을 얻었다.After mixing polyethylene glycol dimethacrylate and β-chitin of each molecular weight prepared in Preparation Example in the composition ratio shown in Table 1 below, 2.4 wt% of the mixture was dissolved in formic acid solution and left for 30 minutes in a nitrogen atmosphere, followed by 0.3 A solution of 2 g of 2,2-dimethoxy-2-phenylacetphenol in 1 ml of N-vinylpyrrolidone was cast on a glass plate and cured for about 60 minutes in a 450 W ultraviolet lamp. Drying in a reduced pressure oven to obtain a chitin-based interpenetrating structure film according to the present invention having a dense surface.
[비교예 1 내지 5][Comparative Examples 1 to 5]
하기 표 1에 기재된 바와 같이, 키틴 또는 폴리에틸렌글리콜디메타크릴레이트를 사용하지 않은 것을 제외하고는 상기 실시예와 동일하게 수행하였다.As shown in Table 1, it was carried out in the same manner as in the above example except that chitin or polyethylene glycol dimethacrylate was not used.
한편, 상기 실시예의 IPN 필름 및 비교예의 가교되지 않고 남아있을 폴리에틸렌글리콜디메타크릴레이트의 열적성질(유리전이온도), 결정화도 등을 열분석기로 측정하고 이온수에서 평행팽윤도(EWC)를 측적하였다. 또한, 인스트른(Instron)을 이용해 건조상태 및 평행팽윤 상태에서의 파단시 인장강도를 측정하여 하기 표 1에 기재하였다.On the other hand, the thermal properties (glass transition temperature), crystallinity, etc. of the polyethylene glycol dimethacrylate, which will remain uncrosslinked in the IPN film of the above example and the comparative example, were measured by a thermal analyzer, and the degree of parallel swelling (EWC) in the ionized water was measured. In addition, Instron was used to measure tensile strength at break in a dry state and in a parallel swelling state.
상기 표 1의 유리전이온도 및 결정화도로 부터 본 발명의 IPN 필름이 가교되어 일정 강도를 유지하면서, 결정화도가 낮아 가공이 용이함을 알 수 있다. 또한, 본 발명에 따른 IPN 필름의 평행팽윤도(함수율)가 50% 이상이고, 습윤시 인장강도가 대부분 1MPa 이상으로써 그 기계적 강도를 유지하고 있음으로 인공피부 및 수술용 봉합사로 매우 적합함을 알 수 있다.It can be seen that the IPN film of the present invention is crosslinked from the glass transition temperature and the degree of crystallization of Table 1 while maintaining a constant strength, so that the degree of crystallinity is low and the processing is easy. In addition, the degree of parallel swelling (water content) of the IPN film according to the present invention is 50% or more, and the tensile strength when wet is mostly 1 MPa or more, which maintains its mechanical strength, making it very suitable for artificial skin and surgical sutures. have.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950019960A KR0148546B1 (en) | 1995-07-07 | 1995-07-07 | Process for preparing interpenetrating polymer network film of chitin for an artificial skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950019960A KR0148546B1 (en) | 1995-07-07 | 1995-07-07 | Process for preparing interpenetrating polymer network film of chitin for an artificial skin |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970005310A KR970005310A (en) | 1997-02-19 |
KR0148546B1 true KR0148546B1 (en) | 1998-11-02 |
Family
ID=19420061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950019960A KR0148546B1 (en) | 1995-07-07 | 1995-07-07 | Process for preparing interpenetrating polymer network film of chitin for an artificial skin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0148546B1 (en) |
-
1995
- 1995-07-07 KR KR1019950019960A patent/KR0148546B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR970005310A (en) | 1997-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4463702B2 (en) | Stretchable collagen molded body, production method and use thereof | |
CN108744055B (en) | Silk fibroin bone cement biological adhesive and preparation method thereof | |
CN110330797A (en) | A kind of double modified gelatin-compounded bio-inks of fibroin albumen-and its preparation method and application of photo-crosslinking | |
US10046087B2 (en) | Collagen based materials | |
CN111821514B (en) | Silk sericin composite membrane and preparation method thereof | |
CN109912850A (en) | Contain the self-healing hydrogel and its preparation method and application of excretion body | |
Ramadoss et al. | Enhanced mechanical strength and sustained drug release of gelatin/keratin scaffolds | |
CN113368312B (en) | Preparation method and application of biodegradable self-adhesive hydrogel | |
Liang et al. | Monomer-induced customization of UV-cured atelocollagen hydrogel networks | |
EP3488876B1 (en) | Novel formula for synthesizing bone replacement material, and manufacturing method and application method thereof | |
CN111793899A (en) | Bionic nanofiber material and preparation method and application thereof | |
Zhai et al. | Mechanically strengthened hybrid peptide-polyester hydrogel and potential applications in spinal cord injury repair | |
CN111671980A (en) | Bionic composite bone scaffold and preparation method thereof | |
CN115337446A (en) | Preparation method of bio-based adhesive hydrogel patch for promoting wound healing, product and application thereof | |
Xu et al. | Engineering air-in-water emulsion as adaptable multifunctional sealant | |
Li et al. | Resveratrol loaded native silk fiber-sericin hydrogel double interpenetrating bioactive wound dressing facilitates full-thickness skin wound healing | |
Zhang et al. | Bioinspired poly (aspartic acid) based hydrogel with ROS scavenging ability as mEGF carrier for wound repairing applications | |
KR0148546B1 (en) | Process for preparing interpenetrating polymer network film of chitin for an artificial skin | |
Li et al. | Papillary fibroblast-recruiting injectable self-healing multifunctional hydrogels for wound regeneration | |
Xu et al. | Dually crosslinked self-healing hydrogels originating from cell-enhanced effect | |
CN108452366B (en) | Cod skin gelatin composite hemostatic dressing and preparation method thereof | |
Yuan et al. | Evaluation of hydrogels for soft tissue adhesives in vitro and in vivo analyses | |
CN110711264B (en) | Composite material, medical adhesive, and preparation method and application thereof | |
KR0161648B1 (en) | Method for producing artificial skin-film | |
Wang et al. | A biocompatible polyethylene glycol/alginate composite hydrogel with significant reactive oxygen species consumption for promoting wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120619 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20130523 Year of fee payment: 16 |
|
LAPS | Lapse due to unpaid annual fee |